Dr Michael Castro is a medical doctor and neuro-oncologist. With an in-depth knowledge of molecular oncology, targeted therapy and immune-oncology, Dr Castro specialises in using tailor-made treatments for cancer patients, and runs Cellworks Precision Medicine where the mission is to serve patients through advances in personalised medicine that significantly improve treatment success.
Cellworks VenturaTM reports provide personalised therapy response predictions to combinations of FDA-approved drugs, including off-label drugs, for refractory patients.
The Cellworks Platform runs exhaustive combinations of drugs from Cellworks drug library to rank the most efficacious treatments for a patient.
This provides physicians treatment options beyond standard care for treatment-refractory patients, for whom there is little guidance on treatment.
Repurposed (off-label) drugs for cancer Personalised medicine
